These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29511464)

  • 1. Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Amiri Dash Atan N; Koushki M; Motedayen M; Dousti M; Sayehmiri F; Vafaee R; Norouzinia M; Gholami R
    Gastroenterol Hepatol Bed Bench; 2017; 10(Suppl1):S1-S7. PubMed ID: 29511464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis.
    Dai W; Ye L; Liu A; Wen SW; Deng J; Wu X; Lai Z
    Medicine (Baltimore); 2017 Sep; 96(39):e8179. PubMed ID: 28953675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
    Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
    J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.
    Mantovani A; Byrne CD; Bonora E; Targher G
    Diabetes Care; 2018 Feb; 41(2):372-382. PubMed ID: 29358469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Zhu Y; Xu J; Zhang D; Mu X; Shi Y; Chen S; Wu Z; Li S
    Front Endocrinol (Lausanne); 2021; 12():769069. PubMed ID: 34956080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    de Vries M; Westerink J; Kaasjager KHAH; de Valk HW
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3842-53. PubMed ID: 32827432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.
    Shalimar ; Elhence A; Bansal B; Gupta H; Anand A; Singh TP; Goel A
    J Clin Exp Hepatol; 2022; 12(3):818-829. PubMed ID: 35677499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of non-alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta-analysis of observational studies.
    Song D; Li C; Wang Z; Zhao Y; Shen B; Zhao W
    J Diabetes Investig; 2021 Aug; 12(8):1471-1479. PubMed ID: 33372390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.
    Mantovani A; Turino T; Altomari A; Lonardo A; Zoppini G; Valenti L; Tilg H; Byrne CD; Targher G
    Metabolism; 2019 Jul; 96():56-65. PubMed ID: 31047909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.
    Mantovani A; Petracca G; Beatrice G; Tilg H; Byrne CD; Targher G
    Gut; 2021 May; 70(5):962-969. PubMed ID: 32938692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
    Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
    Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
    Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
    PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
    Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis.
    Kannan S; Nelliyanil M; Mendagudli R; Rajeshwari S; Kona C; Kundapur R; Sathyanath S; Kulkarni V; Aggarwal S
    J Educ Health Promot; 2023; 12():435. PubMed ID: 38464628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Orfanidou M; Ntenti C; Evripidou K; Mataftsi A; Goulas A; Polyzos SA
    J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511760
    [No Abstract]   [Full Text] [Related]  

  • 17. Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis.
    Wong C; Yaow CYL; Ng CH; Chin YH; Low YF; Lim AYL; Muthiah MD; Khoo CM
    Front Endocrinol (Lausanne); 2020; 11():609135. PubMed ID: 33643221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
    Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
    Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis.
    Foo RX; Ma JJ; Du R; Goh GBB; Chong YS; Zhang C; Li LJ
    EClinicalMedicine; 2024 Jun; 72():102609. PubMed ID: 38707911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.